Mayo Clinic researchers say the combined technologies of microSPECT and microCT imaging can accurately quantify intratumoral radioisotope uptake in vivo, and the hybrid technique is more reliable than planar or microSPECT imaging alone.
The findings are published in the Journal of Molecular Imaging and Biology. The researchers used a dual-modality microSPECT/CT in vivo imaging system from gamma camera developer Gamma Medica-Ideas of Northridge, CA.
In vivo imaging is used to collect quantitation data and improve the accuracy of preclinical research. Quantitation is the process by which researchers measure how much of a drug or therapeutic agent is reaching its target.
By AuntMinnie.com staff writers
October 26, 2006
Related Reading
Gamma Medica-Ideas gets SPECT/MRI development grant, October 5, 2006
Gamma Medica-Ideas introduces eV-CZT digital gamma camera, August 30, 2006
Gamma Medica-Ideas shows Flex Triumph animal imager, June 7, 2006
Gamma Medica-Ideas adds Asian distributors, names director, May 16, 2006
Gamma Medica-Ideas posts strong December, January 20, 2006
Copyright © 2006 AuntMinnie.com
